Literature DB >> 22232238

Purification, characterization, and molecular cloning of lectin from winter buds of Lysichiton camtschatcensis (L.) Schott.

Yuichiro Nakagawa1, Hikaru Sakamoto, Hiroaki Tateno, Jun Hirabayashi, Suguru Oguri.   

Abstract

A novel lectin was purified to homogeneity from winter buds of Lysichiton camtschatcensis (L.) Schott of the Araceae family. It was a tetramer composed of two non-covalently associated polypeptides with small subunits (11 kDa) and large subunits (12 kDa). Sequencing of both subunits yielded unique N-terminal sequences. A cDNA encoding the lectin was cloned. The isolated cDNA contained an open reading frame that encoded 267 amino acids. It encoded both subunits, indicating that the lectin is synthesized as a single precursor protein that is post-translationally processed into two different subunits with 45% sequence identity. Each subunit contained a mannose-binding motif known to be conserved in monocot mannose-binding lectins, but its activity was not inhibited by monosaccharides, including methyl α-mannoside. Asialofetuin and yeast invertase were potent inhibitors. Lectin activity was detected in the buds formed during the winter season but not in the expanded leaves.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232238     DOI: 10.1271/bbb.110346

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  Exploration of carbohydrate binding behavior and anti-proliferative activities of Arisaema tortuosum lectin.

Authors:  Kshema Thakur; Tarnjeet Kaur; Manpreet Kaur; Rachna Hora; Jatinder Singh
Journal:  BMC Mol Biol       Date:  2019-05-07       Impact factor: 2.946

Review 2.  Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.

Authors:  Annick Barre; Els J M Van Damme; Mathias Simplicien; Sophie Le Poder; Bernard Klonjkowski; Hervé Benoist; David Peyrade; Pierre Rougé
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.